Navigation Links
Medicare Approves in Home Sleep Apnea Testing
Date:4/8/2008

Insurance Companies Expected To Match Medicare Policy

SAN CARLOS, Calif., April 8, 2008 /PRNewswire/ -- The Centers for Medicare and Medicaid Services (CMS) have approved at-home sleep testing for obstructive sleep apnea (OSA). Previous policy had mandated that suspected sleep apnea sufferers undergo facility-based polysomnography. The new policy allows continuous positive airway pressure (CPAP) treatment for Medicare patients who are diagnosed via unattended home monitoring devices. This decision will likely prompt increased coverage from insurance companies around the country.

"SleepQuest is very excited about the change in coverage as it demonstrates that our portable sleep testing program, which we have successfully offered for the past 14 years, is a viable and effective alternative to sleep lab testing," said Robert Koenigsberg, SleepQuest President. "Dr. William Dement, SleepQuest's Chief Scientific Advisor and I applaud CMS's in-depth analysis of this topic, providing greater access and allowing the many sufferers of OSA to benefit from treatment."

While coverage has been approved, providers of in-home sleep testing are still waiting to hear the specific date that the policy will actually go into effect. However, several insurance providers have already begun to align their coverage with Medicare.

"We were quite happy to learn that upon hearing of the approval, Aetna immediately revised their medical policy to mirror Medicare's," said Lori Schulman, SleepQuest's Director of Contracting. "We expect other plans that follow Medicare, such as Triwest, will also adopt this policy. SleepQuest has also been in contact with insurance providers, such as Blue Cross of California, who currently allow home sleep testing but impose coverage restrictions."

SleepQuest will continue to work closely with Medicare and insurance companies to ensure that coverage expands, making treatment more available and affordable to more patients. An estimated 30 million Americans suffer from some form of sleep apnea.

SleepQuest has been a leader in at-home testing and treatment of sleep apnea for more than 14 years. With Medicare's official approval, they anticipate significant growth and expansion. A new San Francisco office is scheduled to open by July.

"We anticipate that as coverage continues expanding, we will be able to focus on getting more patients tested quickly and comfortably in the home environment," said Koenigsberg. "We look forward to helping even more OSA sufferers with our comprehensive approach to wellness and vitality."


'/>"/>
SOURCE SleepQuest
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. STAAR Surgicals Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services
2. MedicareCRM(TM) to Speak at IIR Medicare Advantage Congress
3. Medicare Coverage Recommended for In-Home Sleep Testing
4. House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
5. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. 3SBio Inc. Approves Share Repurchase Program
8. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
9. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
10. FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
11. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017  Driven by consumers, preference towards more ... fastest growing categories, finds the recently published U.S. ... Care: Multi-regional Market Analysis and Opportunities study ... Kline. "Biotechnology actives are derived from ... effective for skin and hair care applications," explains ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
Breaking Biology Technology:
(Date:2/22/2017)... With the biometrics market to exceed ... technologies that innovative and agile startups must incorporate ... the changing competitive landscape: multifactor authentication (MFA), point-of-sale ... "Companies can no longer afford to cut ... Dimitrios Pavlakis , Industry Analyst at ABI Research. ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
(Date:2/9/2017)... 9, 2017 The biomass boiler market report ... biomass boiler market globally in terms of revenue (US$ ... The market for biomass boilers has been segmented on ... and country/region. The market based on feedstock type, has ... biogas & energy crops, urban residues, and others. On ...
Breaking Biology News(10 mins):